159 results match your criteria: "Weill Cornell Medical College and New York-Presbyterian Hospital[Affiliation]"

Article Synopsis
  • Myelodysplastic neoplasms/syndromes (MDS) are a diverse set of diseases marked by ineffective blood cell production.
  • Recent classification systems by the World Health Organization and the International Consensus have provided more detailed categorizations of MDS based on morphology and genetics.
  • A comprehensive and systematic approach is essential for the accurate diagnosis and classification of MDS, as outlined by the International Consortium for MDS (icMDS).
View Article and Find Full Text PDF
Article Synopsis
  • Hydroxyurea is typically the first choice for treating high-risk essential thrombocythemia (ET), but some patients can't tolerate it or don't respond, leading to the use of ruxolitinib as an alternative.
  • A post hoc analysis compared clinical outcomes between patients who continued with hydroxyurea and those who switched to ruxolitinib after experiencing issues with hydroxyurea.
  • Results showed that after switching to ruxolitinib, patients experienced significant reductions in both leukocyte and platelet counts over 48 months, demonstrating that ruxolitinib can be an effective option for patients with ET who are intolerant or refractory to hydroxyurea.
View Article and Find Full Text PDF

Early Utilization of Ketorolac in Cleft Palate Repair.

Cleft Palate Craniofac J

May 2024

Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY, USA.

Objective: To determine the effect of ketorolac on opiate requirement and hospital length of stay after palatoplasty.

Design: This was a retrospective chart review.

Setting: This study was completed at an urban tertiary medical center.

View Article and Find Full Text PDF

Notable treatment advances have been made in recent years for patients with myelodysplastic syndromes/neoplasms (MDS), and several new drugs are under development. For example, the emerging availability of oral MDS therapies holds the promise of improving patients' health-related quality of life (HRQoL). Within this rapidly evolving landscape, the inclusion of HRQoL and other patient-reported outcomes (PROs) is critical to inform the benefit/risk assessment of new therapies or to assess whether patients live longer and better, for what will likely remain a largely incurable disease.

View Article and Find Full Text PDF
Article Synopsis
  • - The International Consortium for MDS has updated guidelines on classification, prognostication, and response assessment for myelodysplastic syndromes/neoplasms (MDS), focusing on recent changes in the WHO and ICC classifications.
  • - The report compares traditional risk assessment tools with newer molecular approaches, addressing the limitations of existing criteria in measuring treatment effectiveness.
  • - Emphasizing patient-centered care, the review highlights the importance of quality-of-life assessments and presents how the latest IWG response criteria improve the evaluation of therapeutic outcomes.
View Article and Find Full Text PDF

Background: Allergic inflammation affects the epithelial cell populations resulting in goblet cell hyperplasia and decreased ciliated cells. Recent advances in single-cell RNA sequencing (scRNAseq) have enabled the identification of new cell subtypes and genomic features of single cells. In this study, we aimed to investigate the effect of allergic inflammation in nasal epithelial cell transcriptomes at the single-cell level.

View Article and Find Full Text PDF

Measurement invariance, or the degree to which an instrument measures constructs consistently across subgroups, is critical for appropriate interpretations of measures. Given sex differences in the phenotypic and clinical presentation of autism spectrum disorder (ASD), it is particularly important to examine measurement invariance in autism instruments to ensure that ASD measures are not biased toward the more common male ASD phenotype. This study represents an important preliminary investigation evaluating the measurement equivalence of the Autism Impact Measure (AIM) across children and adolescents with ASD.

View Article and Find Full Text PDF

The Myelofibrosis and Essential Thrombocythemia Observational STudy (MOST; NCT02953704) is an ongoing, noninterventional study assessing clinical characteristics and patient-reported outcomes (PROs) of patients with myelofibrosis (MF) or essential thrombocythemia (ET). This analysis assessed PROs at enrollment; symptom burden and quality of life (QoL), work productivity, and activity were assessed using validated questionnaires in patients with low- or intermediate-1-risk (age-alone) MF, or high- or low-risk ET (receiving ET-directed therapy) at enrollment. In MF and ET cohorts, fatigue had highest mean symptom score.

View Article and Find Full Text PDF
Article Synopsis
  • Allergic rhinitis (AR) is an airway condition characterized by the increase of certain cells in the nasal epithelium, particularly in response to the Th2 cytokine IL-4.
  • Research shows that hyaluronic acid (HA) and its synthases, HAS2 and HAS3, are upregulated in AR and play a significant role in the development of goblet cell hyperplasia.
  • Treatment that inhibits HA synthesis can reduce goblet cell growth and may influence the progression of AR, linking HA levels in nasal fluids to inflammation severity in patients.
View Article and Find Full Text PDF

In castration-resistant prostate cancer (CRPC), the loss of androgen receptor (AR) dependence leads to clinically aggressive tumors with few therapeutic options. We used ATAC-seq (assay for transposase-accessible chromatin sequencing), RNA-seq, and DNA sequencing to investigate 22 organoids, six patient-derived xenografts, and 12 cell lines. We identified the well-characterized AR-dependent and neuroendocrine subtypes, as well as two AR-negative/low groups: a Wnt-dependent subtype, and a stem cell-like (SCL) subtype driven by activator protein-1 (AP-1) transcription factors.

View Article and Find Full Text PDF

Characteristics of 30-Day All-Cause Hospital Readmissions Among Patients with Acute Pancreatitis and Substance Use.

Dig Dis Sci

December 2022

Division of Gastroenterology, Hepatology, and Endoscopy, Center for Pancreatic Disease, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.

Background/objectives: Previous studies on healthcare resource utilization and 30-day readmission risks among patients with acute pancreatitis (AP) have focused upon opioid and alcohol use. The data on other substance types are lacking. In this study we aim to estimate the 30-day readmission rates, predictors of readmission, impact of readmission on patient outcomes and resulting economic burden among patients with AP and substance use in the USA.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic significantly disrupted cardiac diagnostic procedures in Latin America, with volumes dropping by 36% in March 2020 and 82% by April 2020 compared to the previous year.
  • Key tests like echocardiograms and exercise treadmill tests saw the most dramatic declines, with reductions of up to 91%.
  • The study found that changes in social distancing were more closely linked to these volume reductions than the actual incidence of COVID-19 cases, highlighting the need for better management of healthcare access during pandemics.
View Article and Find Full Text PDF

Background And Objectives: Factorial design of a natural experiment was used to quantify the benefit of individual and combined bundle elements from a 4-element discharge transition bundle (checklist, teach-back, handoff to outpatient providers, and postdischarge phone call) on 30-day readmission rates (RRs).

Methods: A 2 factorial design matrix of 4 bundle element combinations was developed by using patient data ( = 7725) collected from January 2014 to December 2017 from 4 hospitals. Patients were classified into 3 clinical risk groups (CRGs): no chronic disease (CRG1), single chronic condition (CRG2), and complex chronic condition (CRG3).

View Article and Find Full Text PDF

Objectives: We explored the variations in use of imaging modalities for confirming pulmonary embolism (PE) according to the trimester of pregnancy.

Methods: We included all pregnant patients with confirmed acute PE from RIETE, a prospective registry of patients with PE (03/2001-02/2020). Imaging modalities included computed tomography pulmonary angiography (CTPA), ventilation-perfusion (V/Q) scan, or presence of signs of acute PE along with imaging-confirmed proximal deep vein thrombosis (pDVT) without pulmonary vascular imaging.

View Article and Find Full Text PDF
Article Synopsis
  • This study analyzed the impact of the COVID-19 pandemic on cardiovascular procedure volumes in the U.S. compared to non-U.S. institutions, finding significant declines across both areas.
  • In April 2020, U.S. facilities experienced a 68% reduction in procedures, similar to the 63% decline in non-U.S. locations, but U.S. invasive coronary angiography procedures dropped more steeply (69% vs. 53%).
  • The study also noted more U.S. facilities adopted telehealth and patient screening measures, with volume reductions varying by region—most significantly in the Northeast and Midwest.
View Article and Find Full Text PDF

Factors Associated With, and Mitigation Strategies for, Health Care Disparities Faced by Patients With Headache Disorders.

Neurology

August 2021

From the Department of Neurology and Neurotherapeutics (J.K.), UT Southwestern Medical Center, Dallas, TX; Department of Neurology (J.V.), Mayo Clinic, Scottsdale, AZ; Division of Neurology (C.L.S., M.A.), Children's Hospital of Philadelphia, PA; Departments of Neurology & Pediatrics (C.L.S.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Department of Neurology (S.T.), School of Medicine, University of Alabama at Birmingham; Departments of Neurology and Population Health (M.T.M.), NYU Langone Health, New York, NY; Department of Neurology (S.B.), Weill Cornell Medical College and New York Presbyterian Hospital, NY; UCSF Benioff Children's Hospital (A.C.R., A.E.W.), University of California, San Francisco; Ferkauf Graduate School of Psychology (M.M.), Yeshiva University, Bronx, NY; Department of Neurology (T.S.M.), University of Miami, Leonard M. Miller School of Medicine, FL; Departments of Neurology and Psychiatry (N.R.), Zucker School of Medicine and Northwell Health, Manhasset, NY; Orofacial Pain (S.L.M.), Division of Diagnostic Sciences, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles; Saul R. Korey Department of Neurology (E.S.), Albert Einstein College of Medicine, Bronx, NY; Carolina Headache Institute (A.F.), University of North Carolina School of Medicine, Durham; and Department of Neurology and Ophthalmology (L.C.), Michigan State University College of Human Medicine, East Lansing.

Objective: To review contemporary issues of health care disparities in headache medicine with regard to race/ethnicity, socioeconomic status (SES), and geography and propose solutions for addressing these disparities.

Methods: An Internet and PubMed search was performed and literature was reviewed for key concepts underpinning disparities in headache medicine. Content was refined to areas most salient to our goal of informing the provision of equitable care in headache treatment through discussions with a group of 16 experts from a range of headache subspecialties.

View Article and Find Full Text PDF

Aim: To evaluate long-term durability of blinatumomab, a BiTE® (bispecific T-cell engager) molecule, in adults with relapsed/refractory (R/R) Philadelphia chromosome-positive (Ph+) B-cell precursor acute lymphoblastic leukaemia (ALL).

Methods: In this final analysis of an open-label, single-arm, phase 2, multicentre ALCANTARA study (NCT02000427), adults (age ≥18 years) with Ph+ ALL who had relapsed or were refractory to at least one TKI were included. The primary endpoint was the proportion of patients who achieved complete remission (CR)/CR with partial haematologic recovery (CRh) during the first two cycles of blinatumomab treatment.

View Article and Find Full Text PDF

Radiation Oncology Applications in Plastic and Reconstructive Surgery: A Nonsystematic Review of Concepts and Principles.

Plast Reconstr Surg

February 2021

From the Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital; George Washington University School of Medicine and Health Sciences; Associates in Radiation Medicine, PC; the Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital; Harvard Medical School; Georgetown University School of Medicine; and the Division of Plastic Surgery, Weill Cornell Medical College and New York-Presbyterian Hospital.

Careful consideration of radiotherapy can determine the success of reconstructive therapy. There is a broad spectrum of radiotherapy modalities, both benign and malignant. Delivery mechanisms differ in the physical design, setup, radiation source, administrable dosage, and mode of delivery.

View Article and Find Full Text PDF

In allergic airway diseases, intermediate progenitor cells (IPCs) increase in number in the surface epithelium. IPCs arise from basal cells, the origin of hallmark pathological changes, including goblet cell hyperplasia and mucus hypersecretion. Thus, targeting IPCs will benefit future treatment of allergic airway diseases.

View Article and Find Full Text PDF

Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips.

Nat Genet

September 2020

State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, CAS Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.

The identification of prostate stem/progenitor cells and characterization of the prostate epithelial cell lineage hierarchy are critical for understanding prostate cancer initiation. Here, we characterized 35,129 cells from mouse prostates, and identified a unique luminal cell type (termed type C luminal cell (Luminal-C)) marked by Tacstd2, Ck4 and Psca expression. Luminal-C cells located at the distal prostate invagination tips (termed Dist-Luminal-C) exhibited greater capacity for organoid formation in vitro and prostate epithelial duct regeneration in vivo.

View Article and Find Full Text PDF

ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming.

J Clin Invest

November 2020

State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.

Although cancer is commonly perceived as a disease of dedifferentiation, the hallmark of early-stage prostate cancer is paradoxically the loss of more plastic basal cells and the abnormal proliferation of more differentiated secretory luminal cells. However, the mechanism of prostate cancer proluminal differentiation is largely unknown. Through integrating analysis of the transcription factors (TFs) from 806 human prostate cancers, we found that ERG was highly correlated with prostate cancer luminal subtyping.

View Article and Find Full Text PDF

Aims: There are significant sex-specific differences in left ventricular ejection fraction (LVEF), with a higher LVEF being observed in women. We sought to assess the clinical relevance of an increased LVEF in women and men.

Methods And Results: A total of 4632 patients from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) registry (44.

View Article and Find Full Text PDF

Transcatheter therapies to treat mitral regurgitation are rapidly developing. Currently, there are several devices commercially available to treat mitral regurgitation. The underlying cause of mitral regurgitation and specific anatomical aspects of the mitral valve and surrounding structures are considered when patients with symptomatic severe mitral regurgitation for transcatheter mitral valve therapies are selected.

View Article and Find Full Text PDF